Parathyroid hormone (1-84) - Kerun Biopharmaceutical

Drug Profile

Parathyroid hormone (1-84) - Kerun Biopharmaceutical

Alternative Names: Recombinant human parathyroid hormone (PTH) 1-84 - Kerun; rhPTH (1-84) - Kerun

Latest Information Update: 08 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kerun Biopharmaceutical
  • Developer Heze Buchang Pharmaceutical; Kerun Biopharmaceutical
  • Class Calcium regulators; Osteoporosis therapies; Peptide hormones
  • Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Osteoporosis

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top